The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Expected Market Size Of The Subcutaneous Drug Delivery Devices Market In 2026 And How Much Will It Reach By 2030?
The market for subcutaneous drug delivery devices has demonstrated significant growth in recent years. This market is forecast to expand from $29.77 billion in 2025 to $32.03 billion in 2026, at a compound annual growth rate (CAGR) of 7.6%. The historical growth of this market can be attributed to several factors, including the rising prevalence of diabetes and chronic diseases, the increasing use of insulin pens and pen needles, the expansion of hospital and clinic infrastructure, the limited availability of advanced delivery technologies, and increasing awareness of subcutaneous drug administration.
The subcutaneous drug delivery devices market is poised for significant expansion over the next few years. Its valuation is predicted to reach $42.42 billion in 2030, growing at a compound annual growth rate (CAGR) of 7.3%. This anticipated growth during the forecast period is influenced by factors such as the rise in biologics and oncology treatments, a greater embrace of smart auto-injectors, the broadening of homecare settings, advancements in implantable pump technologies, and an increasing need for patient-centered drug delivery solutions. Key trends during this period are expected to include the growing adoption of auto-injectors and smart injection devices, a preference for at-home and self-administered therapies, an escalating demand for minimally invasive drug delivery methods, the expansion of biologic and biosimilar drug delivery uses, and improved patient adherence facilitated by user-friendly device designs.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
Which Core Factors Are Supporting The Expansion Of The Subcutaneous Drug Delivery Devices Market?
The rising occurrence of diabetes and cardiovascular diseases (CVD) is anticipated to fuel the expansion of the subcutaneous drug delivery devices market in the future. This growing incidence of diabetes and cardiovascular diseases stems from factors such as aging populations, poor dietary habits, inactive lifestyles, obesity, disparities in socioeconomic status, stress, environmental influences, and insufficient access to preventive medical care. For individuals with diabetes, subcutaneous drug delivery devices facilitate the administration of insulin and other medications to manage blood sugar levels, while in the context of cardiovascular diseases, they deliver drugs like anticoagulants or lipid-lowering agents, thereby offering an accessible and regulated approach for handling these persistent health issues. As an illustration, in October 2024, data from the Centers for Disease Control and Prevention, a US federal agency, indicated that in 2023, 919,032 people died from cardiovascular disease, which accounts for 1 in every 3 deaths. Consequently, the expanding occurrence of diabetes and cardiovascular diseases (CVD) is stimulating market growth for subcutaneous drug delivery devices.
How Is The Subcutaneous Drug Delivery Devices Market Examined Through Segment Analysis?
The subcutaneous drug delivery devices market covered in this report is segmented –
1) By Product Type: Insulin Pens, Pen Needles, Injector Pens, Auto-Injectors, Implantable Pumps
2) By Application: Diabetes, Fertility, Oncology
3) By End-User: Hospitals And Clinics, Homecare Settings, Ambulatory Surgical Centers
Subsegments:
1) By Insulin Pens: Disposable Insulin Pens, Reusable Insulin Pens
2) By Pen Needles: Standard Pen Needles, Safety Pen Needles
3) By Injector Pens: Disposable Injector Pens, Reusable Injector Pens
4) By Auto-Injectors: Manual Auto-Injectors, Smart Auto-Injectors
5) By Implantable Pumps: Insulin Pumps, Drug Infusion Pumps
Which Trends Are Influencing The Direction Of The Subcutaneous Drug Delivery Devices Market?
Leading companies in the subcutaneous drug delivery devices market are focusing on developing innovative products, such as miniature digital liquid flow sensors, to improve the safety and precision of subcutaneous drug delivery by supplying accurate, customizable flow sensors for large-volume injectors. Miniature digital liquid flow sensors are compact instruments that accurately measure the flow rate of liquids in small-scale applications, providing digital output for precise monitoring and control. For instance, in May 2024, Sensirion AG, a Switzerland-based provider of environmental and flow sensors, introduced the SLD3x series sensor platform. This sensor series features highly accurate digital liquid flow sensors with customizable solutions, providing exact flow measurement, occlusion detection, in-line air bubble identification, and liquid temperature monitoring. These miniature sensors are ideal for large-scale medical device manufacturing, ensuring optimal dosing and enhanced patient safety in subcutaneous drug delivery.
Who Are The Companies Shaping The Subcutaneous Drug Delivery Devices Market Landscape?
Major companies operating in the subcutaneous drug delivery devices market are Pfizer Inc., Sanofi S.A., Roche Holdings Inc., Medtronic plc, Eli Lilly and Company, Amgen Inc., Novo Nordisk A/S, Becton Dickinson and Company, West Pharmaceutical Services Inc., Gerresheimer AG, Insulet Corporation, SHL Medical AG, Tandem Diabetes Care Inc., Ypsomed Holding AG, Nemera, Elcam Medical Ltd., Owen Mumford Ltd., Haselmeier GmbH, Sensile Medical AG, Enable Injections Inc., Unilife Corporation, PharmaJet, Oval Medical Technologies Ltd.
Access The Complete Subcutaneous Drug Delivery Devices Market Report:
Which Region Has The Strongest Presence In The Subcutaneous Drug Delivery Devices Market?
North America was the largest region in the subcutaneous drug delivery devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the market going forward. The regions covered in the subcutaneous drug delivery devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Subcutaneous Drug Delivery Devices Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=19723&type=smp
Browse Through More Reports Similar to the Global Subcutaneous Drug Delivery Devices Market 2026, By The Business Research Company
Drug Delivery Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/drug-delivery-devices-global-market-report
Implantable Drug Delivery Devices Market Report 2026
Liposomal Drug Delivery Devices Market Report 2026
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model